First transnational JPIAMR call launched
InnovaResistance, the first joint transnational call of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), which is promoted by 14 funding agencies from 12 countries with a total budget of €13.8m, has been launched.
InnovaResistance’s main aim is to combine the resources, infrastructures and research strengths of multiple countries in order to overcome antibiotic resistance. The goal is to foster multinational translational research collaborations that can accomplish more than individual countries working independently, leading to improved control of bacterial infections.
Dr Marc Ouellette, scientific director of the CIHR Institute of Infection and Immunity, said: “Antimicrobial resistance is one of the top public health problems and requires immediate international action. We are thrilled to start this partnership that will synergise the research efforts of Europeans and Canadians for the development of novel antibiotics and develop strategies that will protect our population from infectious threats.”
The call is a two-step process and by the deadline 15 March, 94 pre-proposals were submitted. The result of the consensus meeting is that 41 pre-proposals have been invited to submit full proposals with a total requested funding of €47.5m.
“We are especially pleased that our first call includes Canada, as this highlights that addressing antimicrobial resistance is a global challenge. To make a difference we need to look beyond Europe,” added Mats Ulfendahl, chair of the JPIAMR management board and representative from the Swedish Research Council.
